Global Custom Market Research Reports Provider Company

phone

Soligenix Inc (SNGX) - Financial and Strategic SWOT Analysis Review

  • Published Date: 05 Jul 2018
  • Number of Pages: 50
  • Category: SWOT Analysis
  • Country: United States of America
Soligenix Inc (SNGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Soligenix Inc (Soligenix) is a late-stage biopharmaceutical company which focuses on the development of products for the treatment of serious inflammatory diseases and biodefense counter measures. It develops biotherapeutics for the treatment of orphan diseases such as cutaneous T-cell lymphoma, pediatric Crohns disease, oral mucositis and acute radiation enteritis. It develops proprietary formulations of oral beclomethasone 17,21-dipropionate (BDP) for the treatment of gastrointestinal disorders that are characterized by high inflammation, including pediatric Crohns disease, acute radiation enteritis and oral mucositis. The company has active development programs for RiVax, a ricin toxin vaccine; VeloThrax, an anthrax vaccine; and OrbeShield, a gastrointestinal acute radiation syndrome therapeutic. These vaccine programs are supported by ThermoVax, a heat stabilization technology. Soligenix is headquartered in Princeton, New Jersey, the US.

Soligenix Inc Key Recent Developments

Jun 28,2018: Soligenix, Prices $8,000,000 Public Offering At The Market
May 11,2018: Soligenix Announces Recent Accomplishments And First Quarter 2018 Financial Results
Mar 15,2018: Soligenix Announces Recent Accomplishments And Year-End 2017 Financial Results
Jan 25,2018: Soligenix - Driving Towards Key Inflection Points with Two Pivotal Phase 3 Clinical Trials
Nov 30,2017: Soligenix to Receive $417,000 in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData


List of Tables 5
List of Figures 5
Section 1 - About the Company 6
Soligenix Inc - Key Facts 6
Soligenix Inc - Key Employees 7
Soligenix Inc - Key Employee Biographies 8
Soligenix Inc - Major Products and Services 9
Soligenix Inc - History 10
Soligenix Inc - Company Statement 14
Soligenix Inc - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 Company Analysis 16
Company Overview 16
Soligenix Inc - Business Description 17
Business Segment: BioTherapeutics Segment 17
Overview 17
Performance 17
Business Segment: Vaccines/BioDefense Segment 17
Overview 17
Performance 17
Soligenix Inc - SWOT Analysis 18
SWOT Analysis - Overview 18
Soligenix Inc - Strengths 18
Soligenix Inc - Weaknesses 19
Soligenix Inc - Opportunities 20
Soligenix Inc - Threats 21
Soligenix Inc - Key Competitors 22
Section 3 Company Financial Ratios 23
Financial Ratios - Capital Market Ratios 23
Financial Ratios - Annual Ratios 24
Performance Chart 26
Financial Performance 26
Financial Ratios - Interim Ratios 27
Financial Ratios - Ratio Charts 28
Section 4 Companys Lifesciences Financial Deals and Alliances 29
Soligenix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Soligenix Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Soligenix Inc, Recent Deals Summary 31
Section 5 Companys Recent Developments 32
Jun 28, 2018: Soligenix, Prices $8,000,000 Public Offering At The Market 32
May 11, 2018: Soligenix Announces Recent Accomplishments And First Quarter 2018 Financial Results 33
Mar 15, 2018: Soligenix Announces Recent Accomplishments And Year-End 2017 Financial Results 34
Jan 25, 2018: Soligenix - Driving Towards Key Inflection Points with Two Pivotal Phase 3 Clinical Trials 35
Nov 30, 2017: Soligenix to Receive $417,000 in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program 38
Nov 06, 2017: Soligenix Announces Recent Accomplishments And Third Quarter 2017 Financial Results 39
Aug 11, 2017: Soligenix Announces Recent Accomplishments And Second Quarter 2017 Financial Results 40
May 11, 2017: Soligenix Announces Recent Accomplishments And First Quarter 2017 Financial Results 42
Mar 27, 2017: Soligenix Announces Recent Accomplishments And Year-End 2016 Financial Results 44
Section 6 Appendix 46
Methodology 46
Ratio Definitions 46
About GlobalData 50
Contact Us 50
Disclaimer 50

List Of Tables

List of Tables
Soligenix Inc, Key Facts 6
Soligenix Inc, Key Employees 7
Soligenix Inc, Key Employee Biographies 8
Soligenix Inc, Major Products and Services 9
Soligenix Inc, History 10
Soligenix Inc, Subsidiaries 15
Soligenix Inc, Key Competitors 22
Soligenix Inc, Ratios based on current share price 23
Soligenix Inc, Annual Ratios 24
Soligenix Inc, Annual Ratios (Cont...1) 25
Soligenix Inc, Interim Ratios 27
Soligenix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Soligenix Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Soligenix Inc, Recent Deals Summary 31
Currency Codes 46
Capital Market Ratios 46
Equity Ratios 47
Profitability Ratios 47
Cost Ratios 48
Liquidity Ratios 48
Leverage Ratios 49
Efficiency Ratios 49

List Of Figures

List of Figures
Soligenix Inc, Performance Chart (2013 - 2017) 26
Soligenix Inc, Ratio Charts 28
Soligenix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Soligenix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30

Soligenix Inc (SNGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

View Report

Soligenix Inc (Soligenix) is a late-stage biopharmaceutical company which focuses on the development of products for the treatment of serious inflammatory diseases and biodefense counter measures. It develops biotherapeutics for

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports